270
Participants
Start Date
September 13, 2023
Primary Completion Date
August 29, 2028
Study Completion Date
August 29, 2028
CC-97540
Specified dose on specified days
Fludarabine
Specified dose on specified days
Cyclophosphamide
Specified dose on specified days
Tocilizumab
Specified dose on specified days
RECRUITING
UZ Leuven, Leuven
RECRUITING
NYU Langone Health, New York
WITHDRAWN
Local Institution - 0054, New York
RECRUITING
Icahn School of Medicine at Mount Sinai, New York
RECRUITING
Columbia University Irving Medical Center, New York
WITHDRAWN
Local Institution - 0055, New York
RECRUITING
Charité Universitaetsmedizin Berlin - Campus Mitte, Berlin
RECRUITING
Hospital Universitario Reina Sofia, Córdoba
RECRUITING
Humanitas, Rozzano
WITHDRAWN
Local Institution - 0030, Baltimore
RECRUITING
The University of North Carolina at Chapel Hill, Chapel Hill
RECRUITING
H.R.U Málaga - Hospital General, Málaga
RECRUITING
Mayo Clinic in Florida, Jacksonville
RECRUITING
University of Miami Hospital and Clinics, Sylvester Cancer Center, Miami
RECRUITING
CHU Bordeaux Haut-Leveque, Pessac
RECRUITING
CHU Montpellier Lapeyronie Hospital, Montpellier
RECRUITING
Centre Hospitalier Universitaire de Rennes - Hôpital Pontchaillou, Rennes
RECRUITING
Hospital Universitario Marqués de Valdecilla, Santander
RECRUITING
Universitaetsklinikum Magdeburg, Magdeburg
RECRUITING
Universitaetsklinikum Duesseldorf, Düsseldorf
WITHDRAWN
Local Institution - 0027, Columbus
RECRUITING
Cleveland Clinic, Cleveland
RECRUITING
Henry Ford Medical Center - New Center One, Detroit
RECRUITING
Universitaetsklinikum Koeln, Cologne
RECRUITING
Mayo Clinic in Rochester, Minnesota, Rochester
RECRUITING
Hopital Claude Huriez - CHU de Lille, Lille
RECRUITING
University of Illinois at Chicago, Chicago
RECRUITING
Washington University School of Medicine, St Louis
NOT_YET_RECRUITING
Local Institution - 0043, Strasbourg
RECRUITING
University Of Nebraska Medical Center, Omaha
RECRUITING
Hôpital Saint-Louis, Paris
RECRUITING
UT Southwestern Medical Center, Dallas
WITHDRAWN
Local Institution - 0052, Paris
RECRUITING
The University of Texas Health Science Center at Houston, Houston
RECRUITING
University of Texas MD Anderson Cancer Center, Houston
RECRUITING
University of Colorado Anschutz Medical Campus, Aurora
RECRUITING
Colorado Blood Cancer Institute, Denver
RECRUITING
Universitaetsklinikum Erlangen, Erlangen
RECRUITING
Universitaetsklinikum Wuerzburg, Würzburg
RECRUITING
Swedish Medical Center, Seattle
NOT_YET_RECRUITING
Local Institution - 0057, Seattle
RECRUITING
Fred Hutchinson Cancer Center, Seattle
WITHDRAWN
Local Institution - 0048, New Haven
NOT_YET_RECRUITING
Local Institution - 0038, Boston
WITHDRAWN
Local Institution - 0046, Boston
NOT_YET_RECRUITING
University of Massachusetts Chan Medical School, Worcester
RECRUITING
University of Massachusetts Chan Medical School, Worcester
RECRUITING
University of Michigan, Ann Arbor
RECRUITING
Atlantic Health System Overlook Medical Center, Summit
RECRUITING
Centre Hospitalier Universitaire de Nice - Hôpital l'Archet, Nice
RECRUITING
Universitätsklinikum Leipzig, Leipzig
RECRUITING
Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Università Cattolica del Sacro Cuore, Rome
RECRUITING
Hospital Universitari Vall d'Hebron, Barcelona
RECRUITING
Hospital Clínic de Barcelona, Barcelona
Bristol-Myers Squibb Services Unlimited Company
UNKNOWN
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
INDUSTRY